Major cancer study seeks best way to protect patients from dangerous chemotherapy side effect

This large, real-world study observed 3000 cancer patients to compare different approaches for preventing and managing neutropenia—a dangerous drop in infection-fighting white blood cells that often follows chemotherapy. Researchers tracked how often patients developed serious infections or severe neutropenia across different treatment strategies. The goal was to find which approaches work best to keep patients safer and improve their quality of life during cancer treatment.